Acquisition of a new analytical ultracentrifuge for advanced biomolecular research
Official title: Acquisition of a Beckman-Coulter Optima AUC Analytical Ultracentrifuge for the University of Montana
Funded at University of Montana · NIH-10853291 · Data updated 2026-11-12
This study is all about getting a special machine that helps scientists at the University of Montana better understand how molecules in our bodies interact, which is really important for learning more about diseases like cancer and genetic disorders, so they can work on new ways to help people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Montana NIH-funded |
| Lab location | 1 site (Missoula, United States) |
| Project start | March 15, 2024 |
| Project end | March 14, 2026 |
| Funding year | 2024 |
| Award (this year) | $586,559 |
| NIH project number | 1S10OD036366-01 |
| Project ID | NIH-10853291 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include patients with breast cancer or genetic conditions that could be studied using advanced biomolecular techniques.
✕Less likely to help
Patients with conditions unrelated to biomolecular interactions or those not participating in research collaborations may not receive direct benefits from this research.
What this research studies
This project aims to acquire a state-of-the-art Beckman-Coulter Optima AUC analytical ultracentrifuge, which will be used to enhance research capabilities at the University of Montana. The instrument will allow researchers to conduct precise measurements of biomolecular interactions and characteristics, which are crucial for understanding various diseases, including cancer and genetic disorders. By integrating this technology into the Center for Biomolecular Structure and Dynamics, the research will support both local and collaborative projects across the United States, providing access to advanced analytical techniques that may not be available elsewhere.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for diseases such as breast cancer and genetic disorders.
How similar studies have gone: Other research utilizing advanced analytical ultracentrifugation has shown promise in enhancing our understanding of biomolecular interactions, indicating that this approach is both valuable and tested.
Where this research is happening
-
University of Montana
Missoula, United States Active
Researchers
- Principal investigator: Demeler, Borries — University of Montana
- Study coordinator: Demeler, Borries
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.